Related references
Note: Only part of the references are listed.Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study
Willemieke P. M. Dijksterhuis et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
G. A. von Dobeln et al.
DISEASES OF THE ESOPHAGUS (2019)
Esophageal and Esophagogastric Junction Cancers, Version 2.2019
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
Fausto Petrelli et al.
GASTRIC CANCER (2019)
Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis
T. E. Kroese et al.
DISEASES OF THE ESOPHAGUS (2018)
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT
Lucas Goense et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis
T. E. Kroese et al.
DISEASES OF THE ESOPHAGUS (2018)
Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer
N. Haj Mohammad et al.
EUROPEAN JOURNAL OF CANCER (2017)
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
F. Klevebro et al.
ANNALS OF ONCOLOGY (2016)
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Lordick et al.
ANNALS OF ONCOLOGY (2016)
Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer
E. Visser et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis
N. Haj Mohammad et al.
CANCER AND METASTASIS REVIEWS (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Surgical Treatment of Adenocarcinomas of the Gastro-esophageal Junction
K. Parry et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
Maarten C. J. Anderegg et al.
PLOS ONE (2015)
The Society of Thoracic Surgeons Practice Guidelines on the Role of Multimodality Treatment for Cancer of the Esophagus and Gastroesophageal Junction
Alex G. Little et al.
ANNALS OF THORACIC SURGERY (2014)
Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Jurriën Stiekema et al.
CLINICAL NUCLEAR MEDICINE (2014)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
Thomas W. Rice et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Detection of interval distant metastases - Clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy
John F. Bruzzi et al.
CANCER (2007)
Share Paper
